CanDiag
Waxhaw
About CanDiag
CanDiag, Inc. is a University of North Carolina Charlotte (UNCC) spin-off that was incorporated in November 2010. Dr. Pinku Mukherjee, Irwin Belk Endowed Professor for Cancer Research at UNCC, is the founder of CanDiag. They have a worldwide exclusive license to a patented tumor antibody that has been used to develop a blood test for the early detection of breast cancer. Their vision is to expand their capabilities and offer services and products ranging from accurate cancer screening kits to targeted drug delivery systems for cancers that affect men and women.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $961.0K
- Last round: Series Unknown (Sep 2013)
- Website: candiaginc.com
- Phone: 7046873128
Industries & Categories
Biotechnology, Commercial, Health Diagnostics, Wellness
Canonical: https://fsome.com/organization/candiag-3306706 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.